SELP and cancer: We believe that the potential complication of soluble P-selectin-induced bleeding or hemorrhage during cancer treatment warrants further clinical investigation, although the risk for soluble P-selectin-induced bleeding or hemorrhage appears to be low and unlikely (Figures 3C and 3G).